Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Mako Surgical offering nets $54.4 million: Robotic knee surgery device maker Mako Surgical nets $54.4 million from a secondary offering of 8.05 million shares of common stock at $7.25 each, completed Aug. 19. The proceeds are tabbed "to support commercialization, sales, marketing and general administrative activities" as well as R&D and working capital, the company explains. In February, the firm rolled out its "next generation" RIO Tactile Guidance System version 2.0 robotic arm and Restoris MCK bi-compartmental knee resurfacing implant. The Fort Lauderdale, Fla., firm, which previously offered versions of the technology for unicompartmental knee procedures, went public in February 2008 (1"The Gray Sheet" Dec. 8, 2008). Underwriters for the most recent offering are Piper Jaffray & Co. and Leerink Swann LLC